trending Market Intelligence /marketintelligence/en/news-insights/trending/ea0bscfh5mgthm10c6q4sq2 content esgSubNav
In This List

OncoCyte names COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


OncoCyte names COO

Alameda, Calif.-based OncoCyte Corp. appointed Albert Parker as COO.

Previously, Parker served as the managing shareholder of GC Legal Advisors. He has also served as executive vice president, general counsel and corporate secretary at Sunovion Pharmaceuticals Inc.

OncoCyte is a biotechnology company and focuses on developing non-invasive blood and urine diagnostic tests for the early detection of cancer.